scholarly journals Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative

2021 ◽  
Vol 30 ◽  
pp. 37-43
Author(s):  
Amit K. Patel ◽  
Brian R. Lane ◽  
Prateek Chintalapati ◽  
Lina Fouad ◽  
Mohit Butaney ◽  
...  
2020 ◽  
Vol 7 (3) ◽  
pp. 20-25
Author(s):  
Lauren Nahouraii ◽  
Jordan Allen ◽  
Suzanne Merrill ◽  
Erik Lehman ◽  
Matthew Kaag ◽  
...  

Pathologic characteristics of extirpated renal cell carcinoma (RCC) specimens <7  cm were reviewed to get better information on technical nuances of renal mass biopsy (RMB). Specimens were stratified according to tumor stage, nuclear grade, size, histology, presence of lymphovas-cular invasion (LVI), necrosis, and sarcomatoid features. When considering pT1 (0–7 cm) tumors pT1b (4–7 cm), RCC masses were more likely to have necrosis (43% vs 16%, P < 0.001), LVI (6% vs 2%, P = 0.024), high-grade nuclear elements (29% vs 17%, P < 0.001), and sarcomatoid features (2% vs 0%, P = 0.006) compared with pT1a (0–4 cm) tumors. Additionally, pT3a tumors were more highly associated with necrosis (P = 0.005), LVI, sarcomatoid features, and high-grade disease (P for all < 0.001) when compared to pT1 masses. For masses <4 cm, pT3a cancers were more likely to demonstrate necrosis (38% vs 16%, P < 0.001), LVI (10% vs 2%, P = 0.037), high-grade nuclear elements (31% vs 17%, P = 0.05), and sarcomatoid features (3% vs 0%, P = 0.065) compared to pT1a tumors. Similarly, for masses 4–7 cm, pathologic T3a tumors were significantly more likely to have sarcomatoid features (16% vs 2%, P < 0.001) and LVI (28% vs 6%, P < 0.001) compared to pT1b tumors. In summary, pT3a tumors and those RCC masses >4 cm exhibit considerable histologic heterogeneity and may harbor elements that are not easily appreciated with limited renal sampling. Therefore, if RMB is considered for renal masses greater than 4 cm or those that abut sinus fat, a multi-quadrant biopsy approach is necessary to ensure adequate sampling and characterization of the mass.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1273-P
Author(s):  
GUY T. ALONSO ◽  
SARAH THOMAS ◽  
COLLEEN GAREY ◽  
DON A. BUCKINGHAM ◽  
ALYSSA B. CABRERA ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1174-P
Author(s):  
RYAN MCDONOUGH ◽  
SARAH THOMAS ◽  
NICOLE RIOLES ◽  
OSAGIE EBEKOZIEN ◽  
MARK A. CLEMENTS ◽  
...  

2021 ◽  
Vol 40 (4) ◽  
pp. S443-S444
Author(s):  
D.N. Rosenthal ◽  
F. Zafar ◽  
C. Villa ◽  
C. Vanderpluym ◽  
D. Peng ◽  
...  

2008 ◽  
Vol 179 (4S) ◽  
pp. 376-376 ◽  
Author(s):  
Alberto Breda ◽  
Leah Haft-Candell ◽  
John T Leppert ◽  
Jonathan W Said ◽  
Robert B Smith ◽  
...  

Author(s):  
Abhishek Srivastava ◽  
Robert N. Uzzo ◽  
Jennifer Lee ◽  
Eric Cho ◽  
Alex Grieco ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document